FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.9  |  FHIR Version n/a  User: [n/a]

714230008: Product containing irinotecan in parenteral dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2016. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3298473017 Parenteral form irinotecan (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
3298598018 Parenteral form irinotecan en Synonym Inactive Only initial character case insensitive SNOMED CT core module
3488586011 Product containing irinotecan in parenteral dosage form (medicinal product form) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
3497654013 Irinotecan in parenteral dosage form en Synonym Inactive Entire term case insensitive SNOMED CT core module
3497655014 Product containing irinotecan in parenteral dosage form en Synonym Inactive Entire term case insensitive SNOMED CT core module
3710467016 Product containing irinotecan in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3710468014 Irinotecan-containing product in parenteral dose form en Synonym Active Entire term case insensitive SNOMED CT core module

5 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing irinotecan in parenteral dose form (medicinal product form) Is a Product containing irinotecan true Inferred relationship Existential restriction modifier
Product containing irinotecan in parenteral dose form (medicinal product form) Is a Product manufactured as parenteral dose form true Inferred relationship Existential restriction modifier
Product containing irinotecan in parenteral dose form (medicinal product form) Has active ingredient Irinotecan true Inferred relationship Existential restriction modifier 1
Product containing irinotecan in parenteral dose form (medicinal product form) Has manufactured dose form Parenteral dose form true Inferred relationship Existential restriction modifier
Product containing irinotecan in parenteral dose form (medicinal product form) Is a Product containing amino acid in parenteral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
Product containing irinotecan in parenteral dose form (medicinal product form) Plays role Antineoplastic therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 2mL vial Is a False Product containing irinotecan in parenteral dose form (medicinal product form) Inferred relationship Existential restriction modifier
Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial Is a False Product containing irinotecan in parenteral dose form (medicinal product form) Inferred relationship Existential restriction modifier
Product containing precisely irinotecan hydrochloride trihydrate 40 milligram/2 milliliter conventional release solution for infusion vial Is a False Product containing irinotecan in parenteral dose form (medicinal product form) Inferred relationship Existential restriction modifier
Product containing precisely irinotecan hydrochloride trihydrate 100 milligram/5 milliliter conventional release solution for infusion vial Is a False Product containing irinotecan in parenteral dose form (medicinal product form) Inferred relationship Existential restriction modifier
Product containing only irinotecan in parenteral dose form (medicinal product form) Is a True Product containing irinotecan in parenteral dose form (medicinal product form) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start